Reversing the Tide: Improving the Recruitment of Patients With Inflammatory Bowel Disease in Clinical Trials in the United States.
Parakkal DeepakPublished in: Crohn's & colitis 360 (2020)
While the number of inflammatory bowel disease (IBD) clinical trials has been increasing, there is decreasing participation in these trials with under-representation of younger patients and those with milder disease and in community settings. Innovative methods to increase recruitment and participation through the use of social media tools, apps, electronic medical record-based patient finding algorithms, and remote monitoring methods are suggested.
Keyphrases
- social media
- clinical trial
- patients with inflammatory bowel disease
- end stage renal disease
- physical activity
- ejection fraction
- newly diagnosed
- health information
- machine learning
- chronic kidney disease
- healthcare
- mental health
- prognostic factors
- case report
- phase ii
- deep learning
- randomized controlled trial
- double blind